[Home]   [Full version]  

Quick microchip test for dangerous antibiotic resistant bacteria

Sep 05 ,General Science


Researchers at the Veterinary Laboratories Agency in Surrey have developed microchips capable of quickly and cheaply identifying dangerous and drug resistant bacteria in clinical samples, scientists announced today at the Society for General Microbiology's 161st Meeting at the University of Edinburgh, UK.

For the first time doctors and veterinarians will be able to test clinical samples from their patients for the presence of the genes for antibiotic resistance in bacteria, getting the results within 24 hours instead of having to wait for as much as a week.

"We have developed a test chip which can accurately identify 56 virulence genes in the diarrhoea-causing Escherichia coli bacteria and 54 antimicrobial resistance genes covering all the known families of gram-negative bacteria", says Dr Muna Anjum from the UK¡¦s Veterinary Laboratories Agency in Addlestone, Surrey.

The chip will speed up the process of diagnosis and treatment by giving quicker results from clinical testing laboratories. The chip will also make it possible to carry out routine surveillance studies to monitor the way genes for virulence and antimicrobial resistance are spread in the environment, food samples, or even in farm and wild animals.

"Our chips have already been used very successfully in a survey of microbial resistance in human clinical isolates, foods, farm animals and also in wild animals, where we were looking at them as possible reservoirs of infection which can transmit disease back into farm animals", says Dr Anjum.

The miniaturised microarray chips were developed by studying and identifying the dangerous genes from samples of gut bacteria including the diarrhoea-causing E. coli bacteria and the food poisoning bug Salmonella.

In a test of the new chip screening technique, the most common antibiotic resistance gene was identified in 90% of E. coli and 56% of Salmonella bacteria from a random group of animal and human clinical samples. The tests even identified some unique and previously unknown combinations of virulence genes, whose significance still needs to be determined.

"In the near future, we are planning to automate the method to enable each sample to be tested for up to 600 genes and for 96 samples to be processed in half a day", says Dr Muna Anjum. "This will allow large scale monitoring of bacterial pathogens to see how they gain and lose genes related to disease and its control".

This technology will also allow scientists to search for and identify important genes from other pathogens and bacteria, for instance genes which may be commercially important in industrial processes such as waste handling, plastics production, manufacturing, food processing or pharmaceutical development.

Source: Society for General Microbiology

Related stories:

Contraceptive pill influences partner choice
The contraceptive pill may disrupt women's natural ability to choose a partner genetically dissimilar to themselves, research at the University of Liverpool has found.
Defining DNA differences to track and tackle typhoid
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
Woolly-Mammoth Gene Study Changes Extinction Theory
A large genetic study of the extinct woolly mammoth has revealed that the species was not one large homogenous group, as scientists previously had assumed, and that it did not have much genetic diversity.
The good news in our DNA: Defects you can fix with vitamins and minerals
As the cost of sequencing a single human genome drops rapidly, with one company predicting a price of $100 per person in five years, soon the only reason not to look at your "personal genome" will be fear of what bad news lies in your genes.
Scientists reveal the lifestyle evolution of wild marine bacteria
Marine bacteria in the wild organize into professions or lifestyle groups that partition many resources rather than competing for them, so that microbes with one lifestyle, such as free-floating cells, flourish in proximity with closely related microbes that may spend life attached to zooplankton or algae.
Leading HIV researchers to collaborate on vaccine development
Two global research organizations dedicated to designing a vaccine against HIV – the International AIDS Vaccine Initiative (IAVI), and the Center for HIV/AIDS Vaccine Immunology (CHAVI) – have signed an agreement to work together to address major biological questions that have slowed development of a safe, effective and affordable AIDS vaccine.
Survival of the fattest: TB accumulates fat to survive -- and spread
Medical scientists from the University of Leicester, together with colleagues from St Georges, University of London, funded principally by the Medical Research Council (MRC) and The Wellcome Trust, have published details of a new breakthrough discovery on TB.
MRSA in hospital intensive care -- what's growing where?
Researchers are finding out which bugs grow in intensive care units to develop a novel sampling regime that would indicate the threat of MRSA and other superbugs in the environment, scientists heard today at the Society for General Microbiology’s 162nd meeting being held this week at the Edinburgh International Conference Centre.

News discussion:

General Science news

[Home]   [Full version]